Randomized, placebo-controlled, double-blind, phase II study of axitinib plus docetaxel versus docetaxel plus placebo in patients with metastatic breast cancer

Hope S. Rugo, Alison T. Stopeck, Anil A. Joy, Stephen Chan, Shailendra Verma, Anna Lluch, Katherine F. Liau, Sinil Kim, Paul Bycott, Brad Rosbrook, Angel H. Bair, Denis Soulieres

Research output: Contribution to journalArticle

87 Scopus citations

Fingerprint Dive into the research topics of 'Randomized, placebo-controlled, double-blind, phase II study of axitinib plus docetaxel versus docetaxel plus placebo in patients with metastatic breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences